Behavioral Symptoms: Clinical Trials

370 trials for Behavioral Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

370 completed. 370 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4370Completed 370

Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms

Trials (filtered) newest first · largest first

All 370 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
Combination of methotrexate and escitalopram in treatment of psoriasis patients with depression and/or anxiety, Methotrexate - Depression, Anxiety
Phase 4CompletedCairo University402026-02-012026-10-05
Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
Bacillus coagulans, placebo - Functional Dyspepsia, Probiotics
Phase 4CompletedXijing Hospital of Digestive Diseases1812025-09-182026-10-13
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 4CompletedIstanbul Training and Research Hospital452025-05-012026-02-24
Impact of Astaxanthin on Cognition in Recreationally Active Females
Astaxanthin, Placebo - Mental Fatigue
Phase 4CompletedUniversity of North Alabama262024-08-012026-05-26
Detoxification From the Lipid Tract
electroencephalogram biofeedback, electrical brain stimulation, ultra-low frequency transcranial magnetic stimulation - COVID-19 Vaccine Adverse Reaction
Phase 4CompletedPachankis, Yang I., M.D.12024-02-262024-04-10
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
normal Saline, Ketamine - Depression, Anxiety
Phase 4CompletedBenha University1102023-10-292026-01-08
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia
Phase 4CompletedBioXcel Therapeutics Inc292023-10-022026-08-11
Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression
toludesvenlafaxine hydrochloride sustained-release tablets - Somatic Symptom
Phase 4CompletedShanghai Mental Health Center602023-05-122025-05-31
Affective Effects of Pre-surgery Opioids: a Randomized, Doubleblind Placebo-controlled Trial
Placebo, Morphine 2.5 mg i.v., Morphine 5 mg i.v. - Opioid Use, Affective Symptoms
Phase 4CompletedOslo University Hospital10142022-12-132026-09-24
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
VTS-K - Treatment Resistant Depression, Major Depressive Disorder
Phase 4CompletedTheresa Jacob, PhD, MPH152022-12-062026-04-21
Fluoxetine Treatment of Depression in Down Syndrome
Fluoxetine - Down Syndrome, Depression
Phase 4CompletedMassachusetts General Hospital42022-12-052025-03-30
Bisoprolol Versus Cognitive Behavioral Therapy for Stress in Patients on Peritoneal Dialysis
Cognitive behavioral therapy, Bisoprolol - Kidney Failure, Chronic, Peritoneal Dialysis, Continuous Ambulatory
Phase 4CompletedUniversitas Sebelas Maret202022-11-102026-10-27
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
Methohexital, Ketofol - ECT, Depression
Phase 4CompletedMedical University of Vienna562022-11-012026-10-07
Brain and Stress Study
Minocycline, Placebo - Stress, Psychological, Motivation
Phase 4CompletedUniversity of North Carolina, Chapel Hill102022-09-122024-12-18
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics
Continuous theta burst stimulation (cTBS), Positive Affect Training, Ketamine Injectable Solution - Depression, Anhedonia
Phase 4CompletedErika Forbes1232022-07-222026-03-17
Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19
Structural and functional MRI, Ethyl methyl hydroxypyridine succinate + Meldonium, Placebo - Asthenia, COVID-19
Phase 4CompletedPromomed, LLC302022-05-182023-07-13
Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression
Sertraline - Efficacy, Team, Adverse Reaction to Drug
Phase 4CompletedFirst Affiliated Hospital of Chongqing Medical University1252022-01-102023-11-09
Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform
Problem Management Plus, Antidepressant Therapy - Depressive Disorder
Phase 4CompletedRAND4872021-09-012026-06-09
Effectiveness of Ketamine Treatment for Three Consecutive Days in Depression
Ketamine Hydrochloride, Midazolam - Depression
Phase 4CompletedMahidol University242021-09-012024-03-15
Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability
Bryophyllum 50 % Chewing Tablets - Anxiety Symptoms
Phase 4CompletedMarkus Schlemmer512021-08-312024-06-21

Showing 20 of 370. Sign in to see all of them.

Narrower conditions

Depression (299)  ·  Depressive Disorder, Major (88)  ·  Psychomotor Agitation (33)  ·  Bipolar Disorder (32)  ·  Depressive Disorder (31)  ·  Anxiety Disorders (29)  ·  Psychotic Disorders (13)  ·  Aggression (12)  ·  Schizophrenia (12)  ·  Suicidal Ideation (12)  ·  Suicide (11)  ·  Alzheimer Disease (10)  ·  Mood Disorders (10)  ·  Dementia (9)  ·  Dysthymic Disorder (9)

Broader conditions

Behavior (366)  ·  Mental Disorders (228)  ·  Mood Disorders (135)  ·  Pathological Conditions, Signs and Symptoms (97)  ·  Depressive Disorder (89)  ·  Signs and Symptoms (86)  ·  Nervous System Diseases (82)  ·  Neurologic Manifestations (69)  ·  Neurobehavioral Manifestations (54)  ·  Aberrant Motor Behavior in Dementia (41)  ·  Dyskinesias (33)  ·  Psychomotor Disorders (33)  ·  Bipolar and Related Disorders (32)  ·  Neurocognitive Disorders (25)

Interventions

Escitalopram (50)  ·  Sertraline (32)  ·  Venlafaxine Hydrochloride (20)  ·  Duloxetine Hydrochloride (18)  ·  Sugars (16)  ·  Ketamine (15)  ·  Citalopram (14)  ·  Fluoxetine (13)  ·  Bupropion (12)  ·  Paroxetine (12)  ·  Quetiapine Fumarate (12)  ·  Lithium (9)  ·  Risperidone (8)  ·  Saline Solution (8)  ·  Dexetimide (7)

Sponsors

New York State Psychiatric Institute (24)  ·  Massachusetts General Hospital (16)  ·  Emory University (13)  ·  University of California, Los Angeles (13)  ·  University of Pittsburgh (13)  ·  Indiana University (10)  ·  Eli Lilly and Company (7)  ·  National Institute of Mental Health (NIMH) (7)  ·  University of Pennsylvania (7)  ·  University of Texas Southwestern Medical Center (6)  ·  University of North Carolina, Chapel Hill (5)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (5)  ·  Forest Laboratories (4)  ·  Sunnybrook Health Sciences Centre (4)  ·  Weill Medical College of Cornell University (4)

Countries

United States (231)  ·  Canada (26)  ·  Germany (11)  ·  China (10)  ·  Italy (10)  ·  Denmark (8)  ·  Netherlands (8)  ·  South Korea (8)  ·  France (7)  ·  Spain (6)  ·  Switzerland (6)  ·  Russia (5)  ·  Turkey (Türkiye) (5)  ·  Austria (4)  ·  Belgium (4)

Top investigators

Amit Anand, MD (7)  ·  David J. Hellerstein, MD (4)  ·  Helen Lavretsky, M.D. (3)  ·  Warren D Taylor, MD, MHSc (3)  ·  Carl Gommoll, MS (2)  ·  Charles Bowden, MD (2)  ·  Dan Iosifescu, MD (2)  ·  Davangere Devanand, M.D. (2)

Results publications

PMID 33884617, PMID 25080392, PMID 24144505, PMID 26803397, PMID 29608461, PMID 30358242, PMID 36999619, PMID 37952772, PMID 40728007, PMID 11442853, PMID 14996777, PMID 15800144, PMID 15956269, PMID 16009352, PMID 16166403, PMID 16168037, PMID 16390886, PMID 16426099, PMID 16457894, PMID 16540613, PMID 16551710, PMID 16554525, PMID 16554526, PMID 16566612, PMID 16566901, PMID 16636629, PMID 16642436, PMID 16690084, PMID 16754414, PMID 16772623, PMID 16816220, PMID 16824617, PMID 16946176, PMID 16946177, PMID 16974189, PMID 17074942, PMID 17091129, PMID 17195602, PMID 17229469, PMID 17302619, PMID 17303771, PMID 17431740, PMID 17685736, PMID 17727882, PMID 17854250, PMID 17917554, PMID 18039992, PMID 18070841, PMID 18162025, PMID 18251622

NIH funding

2005 (2), 2009 (2), R01MH060353 (2), R01MH061017 (2), R01MH072383 (2), 2008 (1), 2016 (1), 2018 (1), 5UL1TR001420-03 (1), K01MH095920 (1), K12HD001441 (1), K23AA017666 (1), K23DA020681 (1), K23MH001828 (1), K23MH064196 (1)